Hours

Minutes

Seconds

-40%

on all subscriptions*

Last hours

Enjoy this offer

* See conditions under "Our services"

Valuation: Stem Cells Spin S.A.

Market Cap	17.2M 4.71M 4.06M 3.74M 3.51M 6.58M 445M 6.65M 44.14M 218M 17.67M 17.29M 755M	P/E Ratio 2024	-15.6x	P/E Ratio 2025	-31.9x
Enterprise Value	17.28M 4.73M 4.08M 3.75M 3.52M 6.62M 447M 6.69M 44.36M 219M 17.75M 17.38M 759M	EV / Sales 2024	151x	EV / Sales 2025	257x
Free-Float	14.73%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Stem Cells Spin S.A.

05-15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-15	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-13	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-14	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-13	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-02-13	Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-02-13	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	CI
24-08-14	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-05-15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-02-14	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
24-02-14	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
23-11-14	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-08-14	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

More news

Managers and Directors: Stem Cells Spin S.A.

Manager	Title	Age	Since
Adam Symber CEO	Chief Executive Officer	45	2016-12-31

Director	Title	Age	Since
Marek Andrzej Cegielski BRD	Director/Board Member	74	2022-06-27
Andrzej Jan Trznadel BRD	Director/Board Member	64	-
Piotr Okoniewski BRD	Director/Board Member	-	2022-03-14

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STEM CELLS SPIN S.A.	-0.95%	+6.67%	+84.07%	+4.52%	4.74M
LONZA GROUP AG	-0.12%	-0.18%	-12.80%	-12.90%	43.58B
REVOLUTION MEDICINES, INC.	-2.17%	+4.70%	+293.71%	+535.99%	34.03B
BEONE MEDICINES AG	-1.60%	-1.58%	-0.19%	+31.82%	29.82B
IQVIA HOLDINGS INC.	+0.44%	-3.80%	+12.51%	-17.06%	29.77B
CELLTRION, INC.	-0.29%	+2.65%	+13.24%	+21.04%	25.42B
ASCENDIS PHARMA A/S	+3.54%	+8.43%	-	-	13.87B
MEDPACE HOLDINGS, INC.	-1.26%	-1.11%	+53.37%	+108.10%	13.35B
EUROFINS SCIENTIFIC SE	-1.04%	-3.48%	+2.42%	+1.98%	12.85B
IONIS PHARMACEUTICALS, INC.	-1.18%	-2.00%	+107.41%	+78.18%	12.22B
Average	-0.46%	+0.84%	+61.53%	+83.52%	21.49B
Weighted average by Cap.	-0.54%	+1.22%	+60.66%	+104.83%

See all sector performances

Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

Employees

Sector

Biotechnology & Medical Research

Calendar

08-13 - Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
26-06-16	0.4160 zł	-0.95%	303
26-06-15	0.4200 zł	+5.00%	401
26-06-12	0.4000 zł	-4.76%	610
26-06-11	0.4200 zł	-1.41%	238
26-06-10	0.4260 zł	+9.23%	1,166

End-of-day quote Warsaw S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Warsaw S.E. Other stock markets 2026-06-16			5-day change	1st Jan Change
0.4160 ^PLN	-0.95%		+6.67%	+2.46%

1 day	-0.95%
1 week	+6.67%
Current month	+15.56%
1 month	+4.00%
3 months	+9.47%
6 months	+7.77%
Current year	+2.46%

1 week	0.37	0.43
1 month	0.36	0.46
Current year	0.33	0.48
1 year	0.18	0.52
3 years	0.14	0.82
5 years	0.14	1.36
10 years	0.14	2.04

	2024	2025
Net sales	54.28K 14.86K 12.8K 11.79K 11.07K 20.79K 1.4M 21.01K 139K 688K 55.76K 54.58K 2.38M	65.74K 17.99K 15.51K 14.28K 13.41K 25.17K 1.7M 25.44K 169K 833K 67.53K 66.1K 2.89M
Net income	-520K -142K -123K -113K -106K -199K -13.46M -201K -1.34M -6.59M -534K -523K -22.85M	-526K -144K -124K -114K -107K -201K -13.6M -203K -1.35M -6.66M -540K -529K -23.09M
Net Debt	69.28K 18.97K 16.34K 15.05K 14.13K 26.53K 1.79M 26.81K 178K 878K 71.17K 69.66K 3.04M	84.58K 23.15K 19.95K 18.37K 17.25K 32.39K 2.19M 32.73K 217K 1.07M 86.89K 85.05K 3.72M

Stem Cells Spin S.A. Stock

Stocks

SCS

PLSTCLS00013

Biotechnology & Medical Research

Valuation: Stem Cells Spin S.A.

Chart: Stem Cells Spin S.A.

Latest news : Stem Cells Spin S.A.

Quotes and Performance

Course Extremes

Managers and Directors: Stem Cells Spin S.A.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates